Merck Lumira Biosciences Fund Holds First Closing at $43M

The newly launched Merck Lumira Biosciences Fund has held its first closing at $43m.

The investment vehicle was establised by Global health care leader Merck (which has made a $35m investment) in collaboration with Lumira Capital, Teralys Capital and other partners.

The fund, which is targeting $50m, will provide capital to support early stage life science innovation in Québec, Canada.

It will be managed by Lumira Capital.



Join the discussion